Design, synthesis, and biological activity of 1,2,3-triazolobenzodiazepine BET bromodomain inhibitors
Journal article
Sharp, Phillip P., Garnier, Jean-Marc, Hatfaludi, Tamas, Xu, Zhen, Segal, David, Jarman, Kate E., Jousset, Hélène, Garnham, Alexandra, Feutrill, John T., Cuzzupe, Anthony, Hall, Peter, Taylor, Scott, Walkley, Carl, Tyler, Dean, Dawson, Mark A., Czabotar, Peter, Wilks, Andrew F., Glaser, Stefan, Huang, David C. S. and Burns, Christopher J.. (2017). Design, synthesis, and biological activity of 1,2,3-triazolobenzodiazepine BET bromodomain inhibitors. ACS Medicinal Chemistry Letters. 8(12), pp. 1298-1303. https://doi.org/10.1021/acsmedchemlett.7b00389
Authors | Sharp, Phillip P., Garnier, Jean-Marc, Hatfaludi, Tamas, Xu, Zhen, Segal, David, Jarman, Kate E., Jousset, Hélène, Garnham, Alexandra, Feutrill, John T., Cuzzupe, Anthony, Hall, Peter, Taylor, Scott, Walkley, Carl, Tyler, Dean, Dawson, Mark A., Czabotar, Peter, Wilks, Andrew F., Glaser, Stefan, Huang, David C. S. and Burns, Christopher J. |
---|---|
Abstract | A number of diazepines are known to inhibit bromo- and extra-terminal domain (BET) proteins. Their BET inhibitory activity derives from the fusion of an acetyl-lysine mimetic heterocycle onto the diazepine framework. Herein we describe a straightforward, modular synthesis of novel 1,2,3-triazolobenzodiazepines and show that the 1,2,3-triazole acts as an effective acetyl-lysine mimetic heterocycle. Structure-based optimization of this series of compounds led to the development of potent BET bromodomain inhibitors with excellent activity against leukemic cells, concomitant with a reduction in c-MYC expression. These novel benzodiazepines therefore represent a promising class of therapeutic BET inhibitors. |
Keywords | benzodiazepine; Bromodomain; JQ1; leukemia; triazole |
Year | 2017 |
Journal | ACS Medicinal Chemistry Letters |
Journal citation | 8 (12), pp. 1298-1303 |
Publisher | American Chemical Society |
ISSN | 1948-5875 |
Digital Object Identifier (DOI) | https://doi.org/10.1021/acsmedchemlett.7b00389 |
Scopus EID | 2-s2.0-85038387097 |
Open access | Published as green open access |
Page range | 1298-1303 |
Research Group | Mary MacKillop Institute for Health Research |
Author's accepted manuscript | File Access Level Open |
Publisher's version | License All rights reserved File Access Level Controlled |
Place of publication | United States of America |
Editors | D. C. Liotta |
https://acuresearchbank.acu.edu.au/item/86qyw/design-synthesis-and-biological-activity-of-1-2-3-triazolobenzodiazepine-bet-bromodomain-inhibitors
Download files
Author's accepted manuscript
AM_Sharp_2017_Design_Synthesis_and_biological_activity.pdf | |
File access level: Open |
Restricted files
Publisher's version
95
total views88
total downloads2
views this month3
downloads this month